CN Stock MarketDetailed Quotes

600332 Guangzhou Baiyunshan Pharmaceutical Holdings

Watchlist
  • 29.85
  • -0.05-0.17%
Market Closed Aug 19 15:00 CST
48.53BMarket Cap11.82P/E (TTM)

Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guangzhou Baiyunshan Pharmaceutical Holdings Q2 2024 Estimates Date

Currency：CNYAug 30, 2024

Estimate YoY
Revenue
19.69B
+7.37%
Analyst Rating
Strong Buy

Aug 19, 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 19.556B--
--2024/Q2-- / 19.693B--
--2024/Q122.946B / 23.143B--
--2023/Q417.331B / 17.382B--
Oct 31, 20232023/Q318.214B / 19.125B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 19.556B--
--2024/Q2-- / 19.693B--
--2024/Q122.946B / 23.143B--
--2023/Q417.331B / 17.382B--
Oct 31, 20232023/Q318.214B / 19.125B--

Unlock Free Earnings Estimates

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Reports

  • Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. 2024 First Quarter Report

    Apr 26 12:00 ET

  • Supplementary Announcement of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. on the 2023 Annual Report

    Mar 22 12:00 ET

  • Full text of the 2023 Annual Report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (revised edition)

    Mar 22 12:00 ET

  • Summary of the 2023 Annual Report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

    Mar 15 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 19, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg